RIO DE JANEIRO, March 12 Amil Participacoes S.A.(Bovespa: AMIL3) ("Amilpar"), in accordance with CVM Instruction 358 ofJanuary 3, 2002, informs that it has signed through its subsidiary AmilAssistencia Medica Internacional Ltda. ("Amil") "Contract for Purchase andSale of Quotas under Suspensive Condition," regarding the totality of quotasrepresentatives of ASL - Assistencia a Saude Ltda. ("ASL") capital for theamount of R$ 8.6 million, to be paid as follows: R$ 4.3 million in the firstbusiness day of the subsequent month following approval by the ANS (BrazilianNational Health Agency), and the balance of the value divided into threemonthly and consecutive installments, the first being due 30 (thirty) daysafter the first payment and the remaining installments in the same day of thefollowing months, adjusted by the accumulated variation of the IPCA (BrazilianConsumer Inflation Index). As part of the deal, Amil will take overcontingencies and liabilities up to the limit of R$ 6 million.
ASL is located in Natal, in the state of Rio Grande do Norte and has atotal membership of approximately 70 thousand members, corresponding to 20.3%market share in the capital's metropolitan region and 15% in the state. Thecompany registered revenues close to R$ 75 million in 2009.
As previously mentioned, the effectiveness of the ASL acquisition and itscorresponding payment is subject to the ANS approval ("Suspensive Condition").
This deal is part of the Company's strategy of growth and expansion in thenortheast region of the country. At the end of 2009, Amilpar had 116 thousandmembers in Pernambuco, 57 thousand in Bahia and now, after this acquisition,totals more than 240 thousand members, or 5% market share in that region.
To access the Notice to Shareholders visit our website atwww.amilpar.com.br/ir
Amil Participacoes S.A. is the largest managed care organization inBrazil, according to the ANS, currently assisting over 5 million members inthe states of Sao Paulo, Rio de Janeiro, Parana, Minas Gerais, Pernambuco,Bahia and in Distrito Federal.IR Contact Erwin Kleuser Investor Relations Officer Phone: +55 (21) 3805-1155 [email protected]